Kyntra Bio, Inc. (KYNB)
4.64
-0.08
(-1.69%)
USD |
NASDAQ |
Oct 29, 15:17
Kyntra Bio Price : 4.64 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 4.54 | 4.72 | 4.37 | 4.72 | 12936.00 |
| Oct 27, 2026 | 4.49 | 4.80 | 4.32 | 4.50 | 6452.00 |
| Oct 26, 2026 | 4.60 | 4.650 | 4.36 | 4.50 | 30072.00 |
| Oct 23, 2026 | 5.09 | 5.09 | 4.56 | 4.580 | 44024.00 |
| Oct 22, 2026 | 5.17 | 5.345 | 5.00 | 5.22 | 9541.00 |
| Oct 21, 2026 | 5.34 | 5.34 | 5.16 | 5.21 | 11794.00 |
| Oct 20, 2026 | 5.27 | 5.45 | 5.261 | 5.28 | 13547.00 |
| Oct 19, 2026 | 5.08 | 5.29 | 4.98 | 5.28 | 21485.00 |
| Oct 16, 2026 | 5.35 | 5.50 | 4.85 | 4.85 | 28808.00 |
| Oct 15, 2026 | 5.50 | 5.73 | 5.34 | 5.36 | 33169.00 |
| Oct 14, 2026 | 5.89 | 5.90 | 5.46 | 5.565 | 36685.00 |
| Oct 13, 2026 | 6.21 | 6.21 | 5.87 | 5.87 | 15927.00 |
| Oct 12, 2026 | 6.15 | 6.34 | 6.01 | 6.12 | 23562.00 |
| Oct 09, 2026 | 6.08 | 6.26 | 6.080 | 6.11 | 6566.00 |
| Oct 08, 2026 | 6.15 | 6.155 | 5.90 | 5.96 | 14960.00 |
| Oct 07, 2026 | 5.85 | 6.35 | 5.85 | 6.13 | 16833.00 |
| Oct 06, 2026 | 6.14 | 6.14 | 5.87 | 5.96 | 13678.00 |
| Oct 05, 2026 | 6.36 | 6.45 | 5.62 | 6.09 | 88804.00 |
| Oct 02, 2026 | 6.60 | 6.635 | 6.30 | 6.31 | 26079.00 |
| Oct 01, 2026 | 6.64 | 6.84 | 6.49 | 6.50 | 23998.00 |
| Sep 30, 2026 | 6.670 | 6.933 | 6.60 | 6.65 | 25472.00 |
| Sep 29, 2026 | 6.80 | 6.950 | 6.64 | 6.79 | 18046.00 |
| Sep 28, 2026 | 6.96 | 7.12 | 6.83 | 6.90 | 12227.00 |
| Sep 25, 2026 | 7.010 | 7.010 | 6.90 | 6.94 | 19745.00 |
| Sep 24, 2026 | 7.175 | 7.175 | 6.98 | 7.00 | 15537.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vericel Corp. | 42.60 |
| Nektar Therapeutics | 38.94 |
| Capricor Therapeutics, Inc. | 6.52 |
| ARS Pharmaceuticals, Inc. | 3.665 |
| ACADIA Pharmaceuticals, Inc. | 20.60 |
Price Related Metrics
| PE Ratio | 0.1436 |
| PS Ratio | 4.066 |
| Earnings Yield | 696.3% |
| Market Cap | 18.79M |
| Normalized PE Ratio | 0.1387 |